OCC 2.60% 39.5¢ orthocell limited

Stem Cell Therapy advancements, page-259

  1. 591 Posts.
    lightbulb Created with Sketch. 66
    I’ve had some serious health issues and was treated terribly by main stream medicine so I know plenty of how it all works and that’s what worries Me.

    You nailed it yourself , regenerative technologies can take away customers from current practices so if they can’t beat them they just lie about their effectiveness

    My Dr has all the data evidence in the world and yet no recognition outside his small amount of peers , however he does see lots of patients and many at the highest sporting level

    I know OCC are doing all the right pathways with the clinical trials and getting the recognition and hopefully it goes main stream but although I’m heavily invested it’s always in the back of my mind the resistance to it

    I’ve done some more research on their technology for ATI and it it’s truly far king amazing

    good luck

    hoping it’s a multi unicorn.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.